{"disease":{"id":"adenocarcinoma-of-the-colon","name":"adenocarcinoma of the colon"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05080673","title":"Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps","phase":"NA","overall_status":"RECRUITING","enrollment_count":9500,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT06978595","title":"Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":8171,"lead_sponsor_name":"asmaa salama ibrahim","has_results":false},{"nct_id":"NCT07319104","title":"Liquid Biopsy in Early Colorectal Lesions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05669430","title":"A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":365,"lead_sponsor_name":"GV20 Therapeutics","has_results":false},{"nct_id":"NCT07070518","title":"Study of GV20-0251 in Participants With Solid Tumor Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"GV20 Therapeutics","has_results":false},{"nct_id":"NCT07129512","title":"Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":304,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06794099","title":"Study on the Applicability of CCR Criteria in Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06791512","title":"mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":166,"lead_sponsor_name":"Jun Huang","has_results":false},{"nct_id":"NCT05197322","title":"NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT04668872","title":"Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT01765790","title":"Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT01652196","title":"Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"John Hays","has_results":true},{"nct_id":"NCT03871959","title":"Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT04005118","title":"Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04624555","title":"The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02425683","title":"Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"US Oncology Research","has_results":false},{"nct_id":"NCT02232152","title":"CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT01814501","title":"Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"John Hays","has_results":true},{"nct_id":"NCT03693846","title":"Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":true},{"nct_id":"NCT04554836","title":"MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"TheraOp","has_results":true},{"nct_id":"NCT02110953","title":"Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Fox Chase Cancer Center","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}